Start a free trial
Menu

AMedP-7.1

AMedP-7.1 medical management of CBRN casualties

Military medical personnel providing CBRN casualty care from the point of exposure through to a role 3 Medical Treatment Facility

AMedP-7.1 is NATO's guidance for medical personnel managing CBRN casualties, setting where responsibility, records and national authority sit alongside the clinical guidance itself.

Edition
A
Published
2018-06

What it is

AMedP-7.1 is NATO's Allied Medical Publication on the medical management of CBRN (chemical, biological, radiological and nuclear) casualties. It gives medical personnel guidance for recognising and managing a casualty affected by a CBRN hazard, from the point of exposure through to a role 3 Medical Treatment Facility; care beyond that point, at a home-nation or allied hospital, is explicitly out of scope. The publication is organised in parts by hazard domain, each built on a shared set of generic principles for CBRN casualty care and a structured approach to managing a CBRN incident as it unfolds, and each gives recognition and management guidance for the trained clinician it addresses.

Who is responsible for what

AMedP-7.1 does not set specific treatment protocols. It says so directly: that remains the responsibility of each member nation, and the protocols the document shows for illustration, supplied by its custodian nation, are something a nation may customise during implementation. The same pattern - NATO guidance, national decision - runs through several other points in the document. Informed consent for sampling in a suspected biological incident is governed by each nation's own medical ethical regulations, not by AMedP-7.1. Specific medical-countermeasure use is directed by national guidance, authorisation and licensing rather than by this publication. Nations may hold their own further guidance on post-exposure risk assessment and follow-up. And where the document does set an operational limit, it defines that limit by reference to the laws of the country where an incident occurs, or to international agreement, rather than by a figure of its own.

Within a response, responsibility is also drawn precisely by role. Personnel decontamination is the operational unit's responsibility; casualty hazard management belongs to the medical chain of command, with support from other units. Management of fatalities is a Command responsibility, with medical personnel expected to support it through advice and occupational medical support, and commanders may be required to add personnel to a post-exposure health register, subject to confidentiality and data-protection constraints. All medical advice on CBRN and outbreak response is meant to be channelled through a single Medical Advisor, who may chair an ad hoc advisory group. Activation of NATO's specialist investigation and response teams is initiated by the Theatre Commander or a higher authority, through the chain of command, following medical advice.

What has to be recorded

Two record-keeping obligations sit apart from the clinical content and apply regardless of hazard domain. Any use of a medical countermeasure, whether self-administered or given by medical staff, should be recorded in the casualty's own health record, and an adverse drug reaction - as distinct from a recognised side effect - should be reported to the relevant national medical or drug regulatory authority. Separately, and specifically for radiological exposures, the recording of contamination and dosimetry information is required in cases of suspected and confirmed exposure, following the recording method set out in a companion Allied Publication. A nominated shipper, suitably qualified for the role, is required to be in charge of consigning any infectious diagnostic samples for shipment.

One reporting obligation reaches outside the medical chain entirely: any reporting of a Public Health Emergency of International Concern under the International Health Regulations (2005) must go through the strategic chain of command, with notice given to each appropriate member nation's defence medical service and civil health service.

How it binds, and what it does not cover

AMedP-7.1 is covered by STANAG 2461, the Standardization Agreement that gives the publication force among the nations that ratify it - ratification and implementation are a nation's own decisions, and this is guidance for a nation's own deployed medical services rather than a document a supplier contracts against directly. AMedP-7.1 names no certification, accreditation or notified-body scheme, and describes no mechanism by which an organisation is assessed against it. What oversight it does describe runs through command and national channels: casualty hazard management sits with the medical chain of command, fatality management is a Command responsibility, and CBRN and outbreak medical advice is meant to be channelled through a single Medical Advisor, not assessed by a third party.

AMedP-7.1 sits inside a wider family of companion CBRN medical publications. AJMedP-7 supplies the CBRN incident cycle the document structures its own incident-management guidance around. It is used as a template, alongside AMedP-7.3, for national CBRN medical training, and stands beside AMedP-7.2 (first aid), AMedP-7.4 (outbreak and incident investigation teams), AMedP-7.5 (casualty estimation) and AMedP-7.6 (command guidance on medical-countermeasure and movement-restriction implementation). Beyond that family it draws on wider doctrine as background, including AJP-3.8 for CBRN defence generally and ATP-45 for warning, reporting and plume-modelling method - cited once as binding for how airborne-contamination monitoring information is used. AMedP-7.1 does not itself set training requirements, first-aid procedures for non-medical personnel, casualty-estimation assumptions or command-level guidance: those sit in the companion publications named above.

How we help

AMedP-7.1 is medical guidance for people already qualified to provide CBRN casualty care. ComplyTrain does not provide clinical capability, training content or CBRN medical support, and nothing here should be read as saying otherwise: the casualty care itself, and the judgement it takes, is exercised by trained clinicians and a nation's own medical chain of command, not by a compliance platform.

Where the fit is real, and it is narrow, is in the record-keeping the document sets independently of its clinical content. AMedP-7.1 asks for contamination and dosimetry information to be recorded for suspected and confirmed radiological exposures, and for medical-countermeasure use and adverse drug reactions to be recorded in a casualty's health record. ComplyTrain can hold that kind of record as a controlled document with a retention and review trail, in the same way it holds any other organisation's compliance records. It does not decide what belongs in the record, generate the record itself, or replace the clinical judgement, training or licensing authority a nation's own medical service exercises.

The applicable tier for a given contract, and the standards that come with it, are set by the contract and the customer's quality clause, not by us. The standards explorer shows what sits alongside AMedP-7.1 in NATO's CBRN medical family - talk to us about the record-keeping your organisation needs to hold.

Standards it references

Questions

Is AMedP-7.1 mandatory?

AMedP-7.1 is covered by STANAG 2461, and it binds a nation once that nation ratifies the agreement - a nation can also ratify with reservations. It does not itself bind a company: there is no supplier-contract mechanism in the document, so whether it is relevant to you depends on your own contract, not on AMedP-7.1 directly.

Does AMedP-7.1 set the treatment a casualty receives?

No. The document is explicit that it does not provide specific treatment protocols; that responsibility sits with each member nation, which may customise the illustrative protocols the document shows. AMedP-7.1 sets the framework and the responsibilities around casualty management, not a fixed procedure.

Can a company be certified against AMedP-7.1?

No. The document names no certification, accreditation or notified-body scheme, and describes no mechanism by which an organisation is assessed against it. Oversight runs through a nation's own medical chain of command, not through third-party certification.

Who does AMedP-7.1 address?

Medical personnel providing CBRN casualty care, from the point of exposure through to a role 3 Medical Treatment Facility. It does not address suppliers or manufacturers directly, and care beyond a role 3 facility is out of its scope.

What does ComplyTrain do with AMedP-7.1?

ComplyTrain does not provide clinical capability, training or CBRN medical support. Its fit is limited to holding the record-keeping the document requires around radiological exposure and medical-countermeasure use as controlled, auditable records - not to the casualty care itself.